Carbon footprint of inhalers in respiratory treatment : SABA CARBON International

Al Zaab, AshrafBell, JohnMontero-Arias, FeliciaPrice, DavidJackson, David JWang, Hao-ChienBudgen, NigelFarouk, HishamMaslova, Ekaterina2023-11-012023-11-012022-12-01Al Zaab, A, Bell, J, Montero-Arias, F, Price, D, Jackson, D J, Wang, H-C, Budgen, N, Farouk, H & Maslova, E 2022, 'Carbon footprint of inhalers in respiratory treatment : SABA CARBON International', European Respiratory Journal, vol. 60, no. Suppl. 66, 2901. https://doi.org/10.1183/13993003.congress-2022.29010903-1936RIS: urn:21DCE4E45CB97FF999A5FAF7919FED70RIS: urn:21DCE4E45CB97FF999A5FAF7919FED70https://hdl.handle.net/2164/22077Funding statement: The study was designed and funded by AstraZeneca3473623engR MedicineRCarbon footprint of inhalers in respiratory treatment : SABA CARBON InternationalJournal item10.1183/13993003.congress-2022.2901http://erj.ersjournals.com/content/60/suppl_66/2901.abstract60